European Journal of Internal Medicine最新文献

筛选
英文 中文
Long-term secondary prevention with colchicine in patients with CAD: an updated systematic review and meta-analysis. 秋水仙碱对冠心病患者的长期二级预防:一项最新的系统综述和荟萃分析。
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-06-06 DOI: 10.1016/j.ejim.2025.04.024
Patrizia Boracchi, Giuseppe Marano, Ester Luconi, Claudio Cimminiello
{"title":"Long-term secondary prevention with colchicine in patients with CAD: an updated systematic review and meta-analysis.","authors":"Patrizia Boracchi, Giuseppe Marano, Ester Luconi, Claudio Cimminiello","doi":"10.1016/j.ejim.2025.04.024","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.04.024","url":null,"abstract":"<p><p>The CLEAR SYNERGY trial failed to demonstrate any benefit of colchicine in patients with acute myocardial infarction (MI). In this meta-analysis of the randomized clinical trials (RCTs) of colchicine in coronary artery disease (CAD), we updated the estimates of effect on cardiovascular events in patients with CAD. We searched for the largest RCTs of colchicine in CAD patients. The effect was assessed in a pooled analysis of individual events such as MI, urgent coronary revascularization (UR), stroke, cardiovascular mortality, and total mortality, for each of these endpoints using hazard ratios (HR) and their 95 % confidence intervals (CI), estimated by the Cox model. Fixed-effects or random-effects models were used. A similar approach was used for the composite of MI, UR, and cardiovascular mortality (MACE 1) and stroke, MI, total mortality (MACE 2). Safety was also assessed. Five studies were selected with a total of 18,656 patients. Colchicine reduced the risk of MI by 21 %, HR 0.79 (95 % CI: 0.68 - 0.92).Its effect was neutral on total and cardiovascular mortality. The composite endpoints MACE 1 and MACE 2 were reduced by colchicine, HR 0.81 (95 % CI: 0.68 - 0.98), and HR 0.88 (95 % CI: 0.79 - 0.98), respectively. There were no differences in non-cardiovascular mortality, cancer, and serious gastrointestinal and infectious events. The benefit of colchicine appears attenuated compared to past analyses, but is still valuable in reducing the risk of MI and the composite of MI, UR, and cardiovascular death. The safety appears reassuring in relation to all serious adverse reactions.</p>","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144250639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastroenteritis caused by Shiga-toxigenic Escherichia coli. Are antibiotics always prohibited in this disease? 由产志贺毒素大肠杆菌引起的肠胃炎。这种疾病是否总是禁止使用抗生素?
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-06-04 DOI: 10.1016/j.ejim.2025.05.035
Juan Gabriel Sánchez-Cano, Ana Belén Mecina-Gutiérrez, Carolina Campelo-Gutiérrez, María Velasco-Arribas, Leonor Moreno-Núñez
{"title":"Gastroenteritis caused by Shiga-toxigenic Escherichia coli. Are antibiotics always prohibited in this disease?","authors":"Juan Gabriel Sánchez-Cano, Ana Belén Mecina-Gutiérrez, Carolina Campelo-Gutiérrez, María Velasco-Arribas, Leonor Moreno-Núñez","doi":"10.1016/j.ejim.2025.05.035","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.05.035","url":null,"abstract":"","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144227455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world glucose-lowering strategies for managing glucocorticoid-induced diabetes in non-intensive hospital settings. 在非重症医院环境中管理糖皮质激素诱导的糖尿病的实际降糖策略
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-06-04 DOI: 10.1016/j.ejim.2025.05.033
Michela Vergani, Matteo Conti, Alessia Lari, Federico Bertuzzi, Basilio Pintaudi
{"title":"Real-world glucose-lowering strategies for managing glucocorticoid-induced diabetes in non-intensive hospital settings.","authors":"Michela Vergani, Matteo Conti, Alessia Lari, Federico Bertuzzi, Basilio Pintaudi","doi":"10.1016/j.ejim.2025.05.033","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.05.033","url":null,"abstract":"","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144235825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phenomena and noumena in nephrology: Beyond the illusion of precision in kidney function assessment. 肾脏病学中的现象与本体:超越对肾功能评估精确度的幻想。
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-06-03 DOI: 10.1016/j.ejim.2025.05.027
Diego Moriconi
{"title":"Phenomena and noumena in nephrology: Beyond the illusion of precision in kidney function assessment.","authors":"Diego Moriconi","doi":"10.1016/j.ejim.2025.05.027","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.05.027","url":null,"abstract":"","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144227457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atypical and fatal presentation of acute liver failure. 急性肝衰竭的非典型和致命表现。
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-06-02 DOI: 10.1016/j.ejim.2025.05.036
Ana Pérez González, Javier Martín López, Jesus Rivera-Esteban
{"title":"Atypical and fatal presentation of acute liver failure.","authors":"Ana Pérez González, Javier Martín López, Jesus Rivera-Esteban","doi":"10.1016/j.ejim.2025.05.036","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.05.036","url":null,"abstract":"","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144217441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Different loop diuretic dosing and administration in acute heart failure (DIUR-AHF): a multicenter prospective observational open-label study. 急性心力衰竭(DIUR-AHF)中不同循环利尿剂剂量和给药:一项多中心前瞻性观察开放标签研究。
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-06-02 DOI: 10.1016/j.ejim.2025.05.026
Alberto Palazzuoli, Filippo Pirrotta, Andrea Stefanini, Antonio Pagliaro, Paolo Severino, Andrea D'Amato, Dario Vizza, Andrea Salzano, Giulia Crisci, Marco Guazzi, Simone Frea, Guido Pastorini, Mauro Feola, Francesco Fedele
{"title":"Different loop diuretic dosing and administration in acute heart failure (DIUR-AHF): a multicenter prospective observational open-label study.","authors":"Alberto Palazzuoli, Filippo Pirrotta, Andrea Stefanini, Antonio Pagliaro, Paolo Severino, Andrea D'Amato, Dario Vizza, Andrea Salzano, Giulia Crisci, Marco Guazzi, Simone Frea, Guido Pastorini, Mauro Feola, Francesco Fedele","doi":"10.1016/j.ejim.2025.05.026","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.05.026","url":null,"abstract":"<p><p>Background Although Loop diuretics (LD) represent the milestone treatment in acute heart failure (AHF), relevant concerns exist about the best administration modality. We aim to investigate the effects of different LD regimen and dosage in patients with AHF. Methods In this multicenter prospective observational open-label study, patients were assigned to receive twice-daily intravenous injections (Bolus infusion, BiV) or continuous intravenous infusion (CiV) of furosemide for a period of 72-120 hours. High dose (HD) was defined as furosemide dose >120 mg/day. Patients were eligible if they showed clinical signs of congestion associated with N-terminal pro-B-type natriuretic peptide (NT-proBNP) >500 pg/ml. Combined of rehospitalisation or death for cardiovascular causes were evaluated as primary endpoint during a 6-months follow-up. Results 402 AHF patients were included, 197 treated with CiV and 205 with BiV. CiV showed higher rate of NTproBNP decrease >30 % (63 % vs 45 %, p < 0.001), associated with significantly weight loss (-4.3 ± 2.6 vs -3.2 ± 2.4 Kg, <0.001) and daily mean urine output (2181 ± 845 ml vs 2019 ± 696 ml, p = 0.036) compared to BiV. Conversely, BiV patients experienced a shorter hospital stay (11.5 ± 4.5 vs 12.7 ± 4.5 days, p = 0.006) and lower adverse events rate (29 % vs 45 %, p = 0.001). HD administration was associated with prolonged hospital stay and poor outcome (55 % vs 18 %). Multivariable analysis confirmed CiV (HR 1.51, 1.02-2.23) and HD infusion (HR 2.50,1.64-3.83) were both associated with the primary endpoints. Conclusions CiV was associated with higher NTproBNP decrease and weight loss but it demonstrates a poorer outcome. Similarly, HD was associated with an increased risk.</p>","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144217442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of malnutrition and its impact on clinical outcomes in internal medicine wards: The SIMI-NUTRO study. 内科病房营养不良患病率及其对临床结果的影响:SIMI-NUTRO研究。
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-06-02 DOI: 10.1016/j.ejim.2025.05.025
Maurizio Muscaritoli, Maria Ida Amabile, Carmen Gallicchio, Giovanni Imbimbo, Caterina Conte, Elisa Ceriani, Antonello Pietrangelo, Elena Corradini, Giuseppe Mandraffino, Gaetano Serviddio, Silvio Buscemi, Ferdinando Carlo Sasso, Clara Balsano, Alberto Moggi Pignone, Alessio Molfino
{"title":"Prevalence of malnutrition and its impact on clinical outcomes in internal medicine wards: The SIMI-NUTRO study.","authors":"Maurizio Muscaritoli, Maria Ida Amabile, Carmen Gallicchio, Giovanni Imbimbo, Caterina Conte, Elisa Ceriani, Antonello Pietrangelo, Elena Corradini, Giuseppe Mandraffino, Gaetano Serviddio, Silvio Buscemi, Ferdinando Carlo Sasso, Clara Balsano, Alberto Moggi Pignone, Alessio Molfino","doi":"10.1016/j.ejim.2025.05.025","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.05.025","url":null,"abstract":"<p><strong>Introduction: </strong>Screening for malnutrition is recommended for all hospitalized patients and can be performed using tools such NRS-2002, MUST, and MNA-SF. Patients at risk should undergo further evaluation for the diagnosis of malnutrition using a validated tool, including the GLIM criteria. This study aimed to evaluate the prevalence of malnutrition and its risk at hospital admission in Internal Medicine Wards, and to assess the impact of malnutrition on the length of stay and on the development of infectious complications.</p><p><strong>Methods: </strong>The SIMI-NUTRO study is a multicenter, observational cohort study conducted in 16 Internal Medicine Wards located in North, Center and South of Italy. Malnutrition risk and diagnosis were assessed by MUST, MNA-SF, and GLIM, respectively.</p><p><strong>Results: </strong>A total of 650 patients were enrolled; 258/610 (42.3 %) were identified as at risk of malnutrition by MUST, while 169/643 (26.3 %) were classified as malnourished by MNA-SF. According to GLIM (n = 625), which requires the presence of at least one etiological and one phenotypic criterion, 233 patients (37.3 %) were considered malnourished. The agreement between MUST and GLIM was moderate (k = 0.55, p < 0.001), as well as between MNA-SF and GLIM (k = 0.49, p < 0.001). Malnourished patients were older and had lower levels of hemoglobin, total cholesterol, and cholinesterase (p < 0.05). Finally, malnutrition was associated with longer hospital stay (p = 0.001) and a higher rate of infectious complications (p = 0.001).</p><p><strong>Conclusions: </strong>The prevalence of malnutrition was high among patients admitted to Internal Medicine Wards distributed in a large national area. Malnutrition was associated with increased number of infections and prolonged hospital stay, underscoring the need for an early identification of nutritional problems.</p>","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144217443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in industry-sponsored research payments to internist principal investigators 行业资助的研究支付给内科首席研究员的趋势。
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-06-01 DOI: 10.1016/j.ejim.2025.01.009
Aurora J. Grutman , Zeyad Hammadeh , Joseph G. Cheaib , Evans K.H. Brown , Misop Han
{"title":"Trends in industry-sponsored research payments to internist principal investigators","authors":"Aurora J. Grutman ,&nbsp;Zeyad Hammadeh ,&nbsp;Joseph G. Cheaib ,&nbsp;Evans K.H. Brown ,&nbsp;Misop Han","doi":"10.1016/j.ejim.2025.01.009","DOIUrl":"10.1016/j.ejim.2025.01.009","url":null,"abstract":"","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":"136 ","pages":"Pages 131-133"},"PeriodicalIF":5.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of sensitization patterns on COPD severity and exacerbations: Insights from a case-control and longitudinal study 致敏模式对COPD严重程度和恶化的影响:来自病例对照和纵向研究的见解
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-06-01 DOI: 10.1016/j.ejim.2025.04.001
Meropi Karakioulaki , Caroline Maria Berkemeier , Leticia Grize , Ingmar Heijnen , Stergios A. Polyzos , Antonis Goulas , Michael Tamm , Daiana Stolz
{"title":"The impact of sensitization patterns on COPD severity and exacerbations: Insights from a case-control and longitudinal study","authors":"Meropi Karakioulaki ,&nbsp;Caroline Maria Berkemeier ,&nbsp;Leticia Grize ,&nbsp;Ingmar Heijnen ,&nbsp;Stergios A. Polyzos ,&nbsp;Antonis Goulas ,&nbsp;Michael Tamm ,&nbsp;Daiana Stolz","doi":"10.1016/j.ejim.2025.04.001","DOIUrl":"10.1016/j.ejim.2025.04.001","url":null,"abstract":"<div><h3>Background</h3><div>Total Immunoglobulin E (tIgE) and allergen-specific IgE (sIgE) have been linked to asthma in numerous studies, with emerging evidence suggesting IgE sensitization influences chronic obstructive pulmonary disease (COPD) onset and severity. This study explores whether (a) serum tIgE and sIgE profiles differ among COPD, asthma, and controls (case-control substudy) and (b) tIgE and 300 individual sIgE levels correlate with disease severity and outcomes in 343 COPD patients (longitudinal substudy).</div></div><div><h3>Methods</h3><div>The case-control substudy measured tIgE and sIgE in 122 participants (76 COPD, 19 asthma, 27 controls). The longitudinal substudy analyzed tIgE and 300 sIgE in 343 COPD patients, examining links to disease severity and outcomes. Atopy was defined as tIgE&gt;20 kUA/L, while skin-sensitization was determined by skin prick test positivity.</div></div><div><h3>Results</h3><div>No significant tIgE differences were observed among asthma, COPD, and controls, however asthma and COPD patients showed distinct sIgE patterns for various allergens. Atopic men reported fewer urgent visits for acute exacerbations of COPD (ECOPD) than non-atopic men (79.07 % vs.91.33 %, p = 0.007), while skin-sensitized women experienced more severe ECOPD than non-skin-sensitized women (46.43 % vs. 24.36 %, p = 0.028). Exacerbation etiology was not associated with atopic or skin-sensitization profiles. Fungal sensitization correlated with older age (p = 0.032), worse 6-minute walking test outcomes (p = 0.007), and reduced diffusion capacity (DLCO/VA %, p = 0.006).</div></div><div><h3>Conclusion</h3><div>While atopic profiles are similar across groups, asthma features higher aeroallergen sIgE. Skin-sensitization and atopy may influence lung function and symptom severity in COPD but are differently associated with ECOPD between sexes and are not linked to the etiology of ECOPD.</div></div>","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":"136 ","pages":"Pages 71-81"},"PeriodicalIF":5.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144054703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disability and caregivers in Italy: Results from an online survey 意大利的残疾与护理人员:在线调查结果。
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-06-01 DOI: 10.1016/j.ejim.2025.01.029
Sergio Harari , Antonella Caminati , Luigi Ripamonti , Paolo Marveggio , Pier Mannuccio Mannucci
{"title":"Disability and caregivers in Italy: Results from an online survey","authors":"Sergio Harari ,&nbsp;Antonella Caminati ,&nbsp;Luigi Ripamonti ,&nbsp;Paolo Marveggio ,&nbsp;Pier Mannuccio Mannucci","doi":"10.1016/j.ejim.2025.01.029","DOIUrl":"10.1016/j.ejim.2025.01.029","url":null,"abstract":"","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":"136 ","pages":"Pages 142-143"},"PeriodicalIF":5.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143191203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信